Raymond James & Associates’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.33M Buy
40,527
+16,663
+70% +$1.69M ﹤0.01% 1754
2024
Q2
$2.36M Sell
23,864
-1,457
-6% -$147K ﹤0.01% 2057
2024
Q1
$2.34M Sell
25,321
-22,300
-47% -$1.8M ﹤0.01% 2065
2023
Q4
$3.6M Buy
47,621
+16,208
+52% +$1.05M ﹤0.01% 1737
2023
Q3
$1.9M Sell
31,413
-10
-0% -$686 ﹤0.01% 2049
2023
Q2
$2.27M Sell
31,423
-4,456
-12% -$282K ﹤0.01% 1977
2023
Q1
$1.99M Sell
35,879
-26,842
-43% -$1.48M ﹤0.01% 2036
2022
Q4
$3.18M Sell
62,721
-3,484
-5% -$172K ﹤0.01% 1714
2022
Q3
$2.79M Sell
66,205
-3,887
-6% -$194K ﹤0.01% 1759
2022
Q2
$3.46M Sell
70,092
-50,973
-42% -$2.53M ﹤0.01% 1650
2022
Q1
$6.38M Buy
121,065
+23,871
+25% +$1.34M 0.01% 1333
2021
Q4
$6.66M Sell
97,194
-15,367
-14% -$1.08M 0.01% 1349
2021
Q3
$8.51M Buy
112,561
+27,265
+32% +$2.34M 0.01% 1149
2021
Q2
$8.53M Buy
85,296
+36,423
+75% +$3.38M 0.01% 1165
2021
Q1
$4.33M Sell
48,873
-54,603
-53% -$5.4M ﹤0.01% 1509
2020
Q4
$9.92M Sell
103,476
-4,327
-4% -$333K 0.01% 953
2020
Q3
$6.55M Sell
107,803
-4,535
-4% -$288K 0.01% 1073
2020
Q2
$7.44M Buy
112,338
+8,033
+8% +$512K 0.01% 973
2020
Q1
$5.82M Sell
104,305
-311
-0.3% -$23.6K 0.01% 964
2019
Q4
$8.78M Sell
104,616
-60
-0.1% -$4.72K 0.01% 960
2019
Q3
$7.74M Sell
104,676
-15,143
-13% -$1.02M 0.01% 985
2019
Q2
$7.5M Sell
119,819
-37,135
-24% -$2.06M 0.01% 1002
2019
Q1
$7.32M Sell
156,954
-5,356
-3% -$284K 0.01% 986
2018
Q4
$7.68M Sell
162,310
-83,124
-34% -$4.39M 0.01% 878
2018
Q3
$15.8M Buy
245,434
+52,258
+27% +$3.3M 0.02% 626
2018
Q2
$11.6M Buy
193,176
+188,460
+3,996% +$11.9M 0.02% 737
2018
Q1
$337K Buy
+4,716
New +$338K ﹤0.01% 2816

Other funds holding ITRI

Raymond James & Associates's ITRI Position: Q3 2024 in Review

Raymond James & Associates increased its Itron (ITRI) stake by 70% in Q3 2024, buying an estimated $1.69M and bringing the position to 40,527 shares worth $4.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

Raymond James & Associates first reported a position in ITRI in Q1 2018 and has held it in 27 quarters since. The position peaked at $15.8M in Q3 2018. 424 funds tracked by Wall St. Rank hold ITRI as of Q3 2024.

  • Raymond James & Associates held 40,527 shares of Itron worth $4.33M as of Q3 2024.
  • Raymond James & Associates bought 16,663 Itron shares in Q3 2024, an estimated $1.69M.
  • Itron made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1754 holding.
  • Raymond James & Associates first reported a position in Itron in Q1 2018 and has held it in 27 quarters since.
  • Raymond James & Associates's Itron position peaked at $15.8M in Q3 2018.
  • 424 funds tracked by Wall St. Rank held Itron as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.